Open AccessPHOTOBIOMODULATION-MEDIATED PATHWAY DIAGNOSTICS
Author(s) -
Timon ChengYi Liu,
Ling Zhu,
Xiangbo Yang
Publication year - 2013
Publication title -
journal of innovative optical health sciences/journal of innovation in optical health science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 24
eISSN - 1793-5458
pISSN - 1793-7205
DOI - 10.1142/s1793545813300012
Subject(s) - function (biology) , dysfunctional family , loss function , biology , gene , microbiology and biotechnology , neuroscience , computational biology , genetics , medicine , phenotype , clinical psychology
Cellular pathways are ordinarily diagnosed with pathway inhibitors, related gene regulation, or fluorescent protein markers. They are also suggested to be diagnosed with pathway activation modulation of photobiomodulation (PBM) in this paper. A PBM on a biosystem function depends on whether the biosystem is in its function-specific homeostasis (FSH). An FSH, a negative feedback response for the function to be performed perfectly, is maintained by its FSH-essential subfunctions and its FSH-non-essential subfunctions (FNSs). A function in its FSH or far from its FSH is called a normal or dysfunctional function. A direct PBM may self-adaptatively modulate a dysfunctional function until it is normal so that it can be used to discover the optimum pathways for an FSH to be established. An indirect PBM may self-adaptatively modulate a dysfunctional FNS of a normal function until the FNS is normal, and the normal function is then upgraded so that it can be used to discover the redundant pathways for a normal function to be upgraded